OR10H5 Inhibitors
OR10H5 Inhibitors consist of a range of chemical compounds that influence the activity of the OR10H5 protein, each through a unique mechanism related to the protein's function or its cellular environment. For instance, quinidine can indirectly inhibit OR10H5 by blocking the sodium channels that are essential for the generation of action potentials in olfactory sensory neurons where OR10H5 is expressed. Similarly, brefeldin A affects OR10H5 by disrupting vesicular transport, hindering the receptor's trafficking to the neuron membrane which is necessary for its function. Concanavalin A, through cross-linking, can potentially prevent OR10H5 from interacting with odorant molecules, thus affecting its olfactory signaling capabilities.
Capsazepine, while not directly targeting OR10H5, may still impact its signaling if both are co-expressed, by influencing the overall membrane potential and neuronal excitability. PMSF, by inhibiting serine proteases, can interfere with the processing of OR10H5, which may lead to its improper maturation and function at the cell surface.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Quinidine is a known blocker of voltage-gated sodium channels. OR10H5 is expressed in olfactory sensory neurons which utilize sodium channels for action potential generation. By blocking these channels, quinidine can indirectly inhibit the neuronal excitability and thus decrease OR10H5-mediated olfactory signaling. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
This compound disrupts protein transport by inhibiting the exchange of GDP to GTP on ADP-ribosylation factor, which is crucial for vesicle formation in the Golgi. By disrupting vesicular transport, Brefeldin A indirectly inhibits the trafficking of OR10H5 to the olfactory receptor neuron membrane, diminishing its functional activity. | ||||||
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $119.00 $364.00 $947.00 | 17 | |
Concanavalin A is a lectin known to cross-link glycoproteins and disrupt cell surface receptor function. Since OR10H5 is a membrane protein with potential glycosylation sites, Concanavalin A can cross-link OR10H5, blocking its access to odorant molecules and decreasing its function. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $148.00 $459.00 | 11 | |
Capsazepine is a known antagonist of the transient receptor potential vanilloid 1 (TRPV1) ion channel. Although it is not a direct inhibitor of OR10H5, it can modulate neuronal excitability and, if co-expressed, could decrease OR10H5 signaling by modulating the membrane potential. | ||||||
Phenylmethylsulfonyl Fluoride | 329-98-6 | sc-3597 sc-3597A | 1 g 100 g | $50.00 $697.00 | 92 | |
PMSF is a serine protease inhibitor that can prevent the proteolytic cleavage of signal peptides for G-protein coupled receptors (GPCRs) like OR10H5. This can lead to the improper processing and maturation of OR10H5, resulting in decreased receptor function. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin is a G-protein signaling antagonist that can inhibit GPCR function. By interfering with G-protein coupled receptor signaling, suramin can reduce OR10H5-mediated signal transduction. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Amiloride is a diuretic that blocks epithelial sodium channels. When these channels are blocked in olfactory sensory neurons, the result can be a reduced membrane depolarization, indirectly decreasing OR10H5 signaling. | ||||||
Clofilium tosylate | 92953-10-1 | sc-391228 sc-391228A | 25 mg 100 mg | $437.00 $1040.00 | 1 | |
This compound is a potassium channel blocker. By inhibiting potassium channels, it can modulate the repolarization phase of action potentials in neurons, potentially dampening the signaling of OR10H5 by affecting the overall neuronal excitability. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine disrupts microtubule polymerization. As microtubules are essential for the trafficking of GPCRs like OR10H5 to the cell surface, colchicine can inhibit the proper localization and function of OR10H5 by destabilizing the cytoskeleton. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole is a proton pump inhibitor that affects the pH balance within intracellular compartments like the Golgi. Altered pH can affect the proper folding and processing of GPCRs such as OR10H5, resulting in decreased receptor activity. | ||||||